TOPICORT GEL 0.05% Strength
Active ingredient(s) See footnote 8 : Strength DESOXIMETASONE : .05 % · DIN 00752541 · HOECHST CANADA INC. 2150 Boul. St-Elzear Ouest Laval Quebec Canada H7L 4A8
Health Canada status: CANCELLED POST MARKET
What is TOPICORT GEL 0.05%?
TOPICORT GEL 0.05% Strength contains Active ingredient(s) See footnote 8 : Strength DESOXIMETASONE : .05 %. It is listed in the Health Canada Drug Product Database under DIN 00752541, held by HOECHST CANADA INC. 2150 Boul. St-Elzear Ouest Laval Quebec Canada H7L 4A8, supplied as Gel for Topical administration. Health Canada currently lists it as cancelled post market, status dated 05-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00752541 |
|---|---|
| Brand name | TOPICORT GEL 0.05% |
| Generic / active ingredient | Active ingredient(s) See footnote 8 : Strength DESOXIMETASONE : .05 % |
| Manufacturer | HOECHST CANADA INC. 2150 Boul. St-Elzear Ouest Laval Quebec Canada H7L 4A8 |
| Strength | Strength |
| Dosage form | Gel |
| Route of administration | Topical |
| Schedule | PRESCRIPTION |
| ATC code | D07AC03 DESOXIMETASONE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 05-Aug-1997 |
| Original market date | 1988-12-31 |
What can be used instead?
Other Canadian products sharing ATC code D07AC03 DESOXIMETASONE. 4 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TOPICORT | 0.05 % | GEL | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02221926 |
| TOPICORT | 0.05 % | CREAM | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02221918 |
| TOPICORT | 0.25 % | CREAM | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02221896 |
| TOPICORT | 0.25 % | OINTMENT | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02221934 |
| DESOXI CREAM 0.05% | 0.05 % | CREAM | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | DORMANT | DIN 02239068 |
| DESOXI CREAM 0.25% | 0.25 % | CREAM | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | DORMANT | DIN 02239069 |
| DESOXI GEL 0.05% | 0.05 % | GEL | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | DORMANT | DIN 02241887 |
| TOPICORT 0.25% | .25 % | CREAM | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00420271 |
| TOPICORT CRM 2.5MG/GM | 2.5 MG | CREAM | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 01987844 |
| TOPICORT GEL 0.05% | Strength | Gel | HOECHST ROUSSEL CANADA INC. 2150 Boul. St-Elzear Ouest Laval Quebec Canada H7L 4A8 | CANCELLED POST MARKET | DIN 01995065 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.